Table 1 Baseline demographic and clinical data of rheumatoid arthritis patients in different 12-month remission statuses
Whole cohort (n = 273) | DAS28 remission (n = 102) | Only DAS28 remission (n = 75) | DAS28 + Boolean remission (n = 27) | Not in any remission (n = 171) | |
|---|---|---|---|---|---|
Age (years) | 59.89 (7 to 85) | 57.12 (7 to 85) | 59.17 (26 to 85) | 51.43 (7 to 75) | 61.53 (30 to 86) |
Disease duration (years) | 13.43 (1 to 52) | 11.1 (1 to 40) | 12,23 (1 to 40) | 7.91 (1 to 21) | 14.68 (1 to 52) |
Female (%) | 74.7 | 68.6 | 66.7 | 74.1 | 78.4 |
RF positivity (%) | 70.2 | 69.7 | 71.2 | 65.4 | 70.5 |
Anti-CCP positivity (%) | 75.2 | 69.4 | 65.7 | 78.6 | 79.7 |
DAS28(4v)-CRP | 5.33 ± 1.07 | 5.15 ± 1.1 | 5.18 ± 1.16 | 5.08 ± 0.9 | 5.44 ± 1.05 |
TJC28 | 10.24 ± 6.86 | 8.71 ± 6.83 | 9.19 ± 7.34 | 7.37 ± 5.05 | 11.15 ± 6.73 |
SJC28 | 9.86 ± 6.20 | 9.6 ± 6.25 | 9.73 ± 6.57 | 9.22 ± 5.36 | 10.02 ± 6.19 |
CRP (mg/dl) | 2.76 ± 2.93 | 3.16 ± 3.14 | 3.23 ± 3.12 | 2.93 ± 3.26 | 2.53 ± 2.78 |
PGH | 5.92 ± 2.28 | 5.6 ± 2.29 | 5.57 ± 2.33 | 5.68 ± 2.22 | 6.12 ± 2.26 |